Quaker Houghton · NYSE:KWR
Quaker Houghton — Q1 2026 Earnings Presentation
15 slides from Quaker Houghton's earnings presentation, May 1, 2026
Slide 1: First Quarter 2026 Results Investor Conference Call
Quaker Houghton First Quarter 2026 Results Investor Conference Call
Slide 2: Forward-Looking Statements
Forward-Looking Statements Forward-Looking Statements This presentation contains “forward-looking statements” that fall under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and the Securities Act of 1933, as amended. These statements can be identified by the fact
Slide 3: Non-GAAP Measures
Non-GAAP Measures The information in this presentation includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, taxes on income before equity in net income of associated companies – adjust
Slide 4: Speakers
Speakers Joe Berquist Chief Executive Officer, President Tom Coler Executive Vice President, Chief Financial Officer Robert T. Traub Senior Vice President, General Counsel & Corporate Secretary John Dalhoff Director, Investor Relations 4 ©2026 Quaker Houghton. All Rights Reserved
Slide 5: Q1'26 Highlights
Q1’26 Highlights $480m $73m Net Sales Adjusted EBITDA1 $1.63 2.3x Non-GAAP Leverage Ratio1,2 Earnings per Diluted Share1 1 This is a non-GAAP measure, refer to the reconciliations of our non-GAAP measures to their most comparable GAAP measures provided within this presentation and in our SEC filings
Slide 6: Financial Snapshot
Financial Snapshot (Unaudited; Dollars in millions, unless otherwise noted) Q1 2026 Q1 2025 Variance(1) GAAP Net sales $ 480.5 $ 442.9 $ 37.6 8.5% Operating income 33.6 27.6 6.0 21.6% Operating income margin (%) 7.0% 6.2% 0.8% Net income 19.7 12.9 6.8 52.8% Earnings per diluted share 1.13 0.73 0.40
Slide 7: Total Company Volume Trend
Total Company Volume Trend1 (kilograms) Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Sales volumes increased by 3% in Q1’26 compared to Q1’25, primarily due to continued growth in the Asia/Pacific segment and new business wins across all segments, helping to offset a conti
Slide 8: Adjusted EBITDA
Adjusted EBITDA1 (dollars in millions) $320 $311 $303 $299 $73 $69 $257 2 2022 2023 2024 2025 Q1'26 LTM Q1 2026 Q1 2025 Generated $73m of adjusted EBITDA in Q1’26, an increase of 5% year-over-year 1 This is a non-GAAP measure, refer to the reconciliations of our non-GAAP measures to their most compa
Slide 9: Leverage and Liquidity Update
Leverage and Liquidity Update Net Debt and Leverage Ratio1 • Total debt of $875 million (Dollars in Millions) • Cash and cash equivalents of $170 million $787 $815 $774 • Net debt of $705 million $765 $753 $735 $696 $703 $691 $705 • Leverage of 2.3x as of March 31, 20261 $628 ◦ In April 2025, we fun
Slide 10: Appendix
Appendix Actual and Non-GAAP Results
Slide 11: Non-GAAP Operating Income Reconciliation
Non-GAAP Operating Income Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) Three Months Ended March 31, Non-GAAP Operating Income and Margin Reconciliations 2026 2025 Operating income $ 33,589 $ 27,624 Restructuring and related charges, net 7,381 14,590 Acquisition-related ex
Slide 12: Adjusted EBITDA Reconciliation
Adjusted EBITDA Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) Three Months Ended March 31, EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin Reconciliations: 2026 2025 Net income attributable to Quaker Chemical Corporation $ 19,669 $ 12,922 Depreciation and amortization 25,8
Slide 13: Adjusted EBITDA Reconciliation
Adjusted EBITDA Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) Twelve Months Ended December 31, EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin Reconciliations: 2025 2024 2023 2022 Net income attributable to Quaker Chemical Corporation $ (2,488) $ 116,644 $ 112,748 $ (1
Slide 14: Non-GAAP EPS Reconciliation
Non-GAAP EPS Reconciliation Three Months Ended March 31, Non-GAAP Earnings per Diluted Share Reconciliations 2026 2025 GAAP earnings per diluted share attributable to Quaker Chemical Corporation common shareholders $ 1.13 $ 0.73 Equity income in a captive insurance company (0.03) (0.04) Restructurin
Slide 15: Segment Performance
Segment Performance (Unaudited; Dollars in thousands, except per share amounts) Three Months Ended March 31, 2026 2025 Net sales Americas $ 213,728 $ 213,711 EMEA 142,083 129,278 Asia/Pacific 124,668 99,925 Total net sales $ 480,479 $ 442,914 Segment operating earnings Americas $ 53,947 $ 58,462 EME